Ebola Claims Land Firms In SEC Doghouse, NAD Review
This article was originally published in The Tan Sheet
Executive Summary
SEC suspends trading for four firms linked to fraudulent Ebola claims and issues an investor alert about the potential for fraud in microcap companies purportedly involved in preventing, testing or treating the virus. Meanwhile, NAD reports an online retailer discontinued an ebola claim for its herbal supplement.